182 related articles for article (PubMed ID: 35960946)
1. The Evolving Landscape of ASCVD Risk Among Patients With HIV.
Malvestutto C
J Fam Pract; 2022 Jul; 71(6 Suppl):S58-S62. PubMed ID: 35960946
[TBL] [Abstract][Full Text] [Related]
2. Underprescribing of statin therapy in people with HIV at risk for atherosclerotic cardiovascular disease.
Gallegos Aragon K; Ray G; Conklin J; Stever E; Marquez C; Magallanes A; Anderson J; Jakeman B
Am J Health Syst Pharm; 2022 Nov; 79(22):2026-2031. PubMed ID: 35976174
[TBL] [Abstract][Full Text] [Related]
3. Detecting and Managing ASCVD in Women: A Focus on Statins.
Kushner P
J Fam Pract; 2022 Jul; 71(6 Suppl):S17-S22. PubMed ID: 35960940
[TBL] [Abstract][Full Text] [Related]
4. Current pharmacotherapy for the treatment of dyslipidemia associated with HIV infection.
Gebhardt A; Fichtenbaum CJ
Expert Opin Pharmacother; 2019 Oct; 20(14):1719-1729. PubMed ID: 31232617
[No Abstract] [Full Text] [Related]
5. Variation in statin prescription among veterans with HIV and known atherosclerotic cardiovascular disease.
Erqou S; Papaila A; Halladay C; Ge A; Liu MA; Jiang L; Lally M; Menon A; Shah NR; Miech E; Virani SS; Zullo AR; Shireman TI; Longenecker CT; Ross D; Sullivan JL; Wu WC; Rudolph JL
Am Heart J; 2022 Jul; 249():12-22. PubMed ID: 35318028
[TBL] [Abstract][Full Text] [Related]
6. Atherosclerotic cardiovascular disease thresholds for statin initiation among people living with HIV in Thailand: A cost-effectiveness analysis.
Boettiger DC; Chattranukulchai P; Avihingsanon A; Chaiwarith R; Khusuwan S; Law MG; Ross J; Kiertiburanakul S
PLoS One; 2021; 16(9):e0256926. PubMed ID: 34499685
[TBL] [Abstract][Full Text] [Related]
7. Low-density lipoprotein cholesterol response after statin initiation among persons living with human immunodeficiency virus.
Burkholder GA; Muntner P; Zhao H; Mugavero MJ; Overton ET; Kilgore M; Drozd DR; Crane HM; Moore RD; Mathews WC; Geng E; Boswell S; Floris-Moore M; Rosenson RS
J Clin Lipidol; 2018; 12(4):988-998.e5. PubMed ID: 29853312
[TBL] [Abstract][Full Text] [Related]
8. Implementation of Cholesterol-Lowering Therapy to Reduce Cardiovascular Risk in Persons Living with HIV.
Wang SC; Kaur G; Schulman-Marcus J; Purga S; Mookherjee S; Miller C; Sidhu MS; Rosenson RS
Cardiovasc Drugs Ther; 2022 Feb; 36(1):173-186. PubMed ID: 32979175
[TBL] [Abstract][Full Text] [Related]
9. Cardiovascular health among persons with HIV without existing atherosclerotic cardiovascular disease.
McLaughlin MM; Durstenfeld MS; Gandhi M; Greene M; Ma Y; Beatty AL; Hsue PY
AIDS; 2023 Nov; 37(14):2179-2183. PubMed ID: 37498162
[TBL] [Abstract][Full Text] [Related]
10. Under-utilization of statins among people with HIV who were aged 40 years or older.
Wu PY; Sun HY; Huang YS; Liu WD; Lin KY; Luo YZ; Chang HY; Chen LY; Chen YT; Hung CC
J Microbiol Immunol Infect; 2024 Feb; 57(1):200-203. PubMed ID: 38233294
[TBL] [Abstract][Full Text] [Related]
11. Evolocumab in HIV-Infected Patients With Dyslipidemia: Primary Results of the Randomized, Double-Blind BEIJERINCK Study.
Boccara F; Kumar PN; Caramelli B; Calmy A; López JAG; Bray S; Cyrille M; Rosenson RS;
J Am Coll Cardiol; 2020 May; 75(20):2570-2584. PubMed ID: 32234462
[TBL] [Abstract][Full Text] [Related]
12. Patients Living With HIV Are Less Likely to Receive Appropriate Statin Therapy for Cardiovascular Disease Risk Reduction.
Emmons RP; Hastain NV; Miano TA; Schafer JJ
J Pharm Pract; 2022 Aug; 35(4):568-572. PubMed ID: 33678059
[TBL] [Abstract][Full Text] [Related]
13. National lipid association recommendations for patient-centered management of dyslipidemia: part 1--full report.
Jacobson TA; Ito MK; Maki KC; Orringer CE; Bays HE; Jones PH; McKenney JM; Grundy SM; Gill EA; Wild RA; Wilson DP; Brown WV
J Clin Lipidol; 2015; 9(2):129-69. PubMed ID: 25911072
[TBL] [Abstract][Full Text] [Related]
14. Comparison of four international cardiovascular disease prediction models and the prevalence of eligibility for lipid lowering therapy in HIV infected patients on antiretroviral therapy.
Begovac J; Dragović G; Višković K; Kušić J; Perović Mihanović M; Lukas D; Jevtović Đ
Croat Med J; 2015 Feb; 56(1):14-23. PubMed ID: 25727038
[TBL] [Abstract][Full Text] [Related]
15. Lipid-Lowering Therapy and Low-Density Lipoprotein Cholesterol (LDL-C) Goal Achievement in High-Cardiovascular-Risk Patients in Fuzhou, China.
Wang X; He Y; Wang T; Li C; Ma Z; Zhang H; Ma H; Zhao H
J Cardiovasc Pharmacol Ther; 2020 Jul; 25(4):307-315. PubMed ID: 31918567
[TBL] [Abstract][Full Text] [Related]
16. Five-Year Residual Atherosclerotic Cardiovascular Disease Risk Prediction Model for Statin Treated Patients With Known Cardiovascular Disease.
Wong ND; Zhao Y; Xiang P; Coll B; López JAG
Am J Cardiol; 2020 Dec; 137():7-11. PubMed ID: 32991855
[TBL] [Abstract][Full Text] [Related]
17. Optimizing Dyslipidemia Management for the Prevention of Cardiovascular Disease: a Focus on Risk Assessment and Therapeutic Options.
Berman AN; Blankstein R
Curr Cardiol Rep; 2019 Aug; 21(9):110. PubMed ID: 31378838
[TBL] [Abstract][Full Text] [Related]
18. Alirocumab therapy in individuals with type 2 diabetes mellitus and atherosclerotic cardiovascular disease: analysis of the ODYSSEY DM-DYSLIPIDEMIA and DM-INSULIN studies.
Ray KK; Del Prato S; Müller-Wieland D; Cariou B; Colhoun HM; Tinahones FJ; Domenger C; Letierce A; Mandel J; Samuel R; Bujas-Bobanovic M; Leiter LA
Cardiovasc Diabetol; 2019 Nov; 18(1):149. PubMed ID: 31706300
[TBL] [Abstract][Full Text] [Related]
19. Treating Dyslipidemias in the Primary Prevention of Atherosclerotic Cardiovascular Disease in Older Adults with Diabetes Mellitus.
Tan M; MacEachern MP
Clin Geriatr Med; 2020 Aug; 36(3):457-476. PubMed ID: 32586475
[TBL] [Abstract][Full Text] [Related]
20. Differences in statin utilization and lipid lowering by race, ethnicity, and HIV status in a real-world cohort of persons with human immunodeficiency virus and uninfected persons.
Riestenberg RA; Furman A; Cowen A; Pawlowksi A; Schneider D; Lewis AA; Kelly S; Taiwo B; Achenbach C; Palella F; Stone NJ; Lloyd-Jones DM; Feinstein MJ
Am Heart J; 2019 Mar; 209():79-87. PubMed ID: 30685678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
